BioCryst Pharmaceuticals is a global biotechnology company committed to improving the lives of people with complement-mediated and other rare diseases through structure-guided drug design. With headquarters in Durham, NC, and Dublin, Ireland, they develop first-in-class oral small-molecule and protein therapeutics for difficult-to-treat diseases.
